sonicated for 10 s three times on ice and transferred to 50 mL tubes and centrifuged for 30 min at 30,000g at 4 °C to pellet cell debris. The cleared lysate was transferred to 2 mL of pre-washed nickel-NTA bead (Qiagen, Valencia, CA) slurry and incubated for 1 h at 4 °C. Thereafter, the nickel-NTA beads were rinsed three times with 20 mL of binding buffer (50 mM Tris, 500 mM NaCl, 0.1% TWEEN20, 20 mM imidazole, 10 mM β-mercatoethanol, pH=7). The His-tagged proteins were then eluted by addition of 5 mL of elution buffer (50 mM Tris, 500 mM NaCl, 250 mM imidazole, 10 mM beta-mercatoethanol) to the bead bed. Eluted protein was subjected to dialysis (50 mM Tris, 50 mM NaCl, 10% glycerol, 0.5 mM DTT) in a 10-kDa molecular weight cutoff membrane (Spectrum Laboratory Products, Inc., Gardena, CA) to remove the imidazole and exchange buffer. The purified proteins were analyzed by SDS-PAGE to ensure homogeneity, concentrated with 30 kDa cutoff concentrator tubes, assayed, and the remainder was flash-frozen using liquid nitrogen and stored at -80 C for later assays.
AmbP1/WelP1/FidP1 in vitro assay. For a typical AmbP1 assay, 5 µM of AmbP1 was added to a 50 µL reaction containing 50 mM Tris-HCl pH 8.0, 0.5 mM (Z)-1 or (E)-1, 0.5 mM GPP, 5 mM MgCl 2 , at 30 °C. All assays were stopped at indicated time by extraction with ethyl acetate (0.5 mL x 2). The combined organic layer was dried under a stream of N 2 gas, and redissolved in methanol (100 µL). A 40-µL aliquot was used for HPLC and LC-HRMS analysis for product identification. For optimizing assay conditions, alternative buffers (MES buffer for pH <7 and Tris buffer for pH>7), metal ions (ZnCl 2 , CaCl 2 , MnCl 2 ) or EDTA were used as indicated. For substrate scope studies, DMAPP, NPP and FPP were used as GPP alternative. (E)-1, 4 and 5 were used as (E)-1 alternative. For kinetics, AmbP1 concentration was fixed at 0.1 µM, GPP concentration was fixed at 0.5 mM and (Z)-1 concentration was varied from 1 µM to 200 µM. Reactions were stopped after 2 min and conversions were estimated based on HPLC with analytical standards.
Structure determination of the AmbP1 enzymatic products. For product 2, assays were scaled to 5 mL. Enzymatic mixtures containing 50 mM Tris buffer (pH 9.0), 20 mM MgCl 2 , 1 mM (Z)-1, 1mM GPP with 1 µM AmbP1 were incubated overnight at 30 °C. For 3, assays were scaled to 5 mL.
Enzymatic mixtures containing 50mM MES (pH 6.0), 10 mM EDTA, 1 mM (Z)-1, 1mM GPP with 1 µM AmbP1 were incubated overnight at 30 °C. Each of the enzymatic products were extracted from the buffer with equal volume ethyl acetate twice, dried, redissolved in methanol, filtered and further purified using a 250 x 4.6 mm Luna C18 5 micron HPLC column (Phenomenex, Torrance, CA), with a gradient from 50-80% acetonitrile in 2-35 min. The dried products were re-dissolved in 40 µL of CD 3 OD or CD 3 Cl and analyzed in a 1 mm capillary NMR tube using a Bruker 700 MHz NMR spectrometer equipped with a capillary probe. The structure of product 5 was determined in an analogous manner.
AmbP1 expression and purification for NMR study: AmbP1 gene encoding residues 1−309 was inserted into the pET-15b(+) expression vector (Novagen), using NdeI and XhoI restriction sites at the 5' and 3' ends, respectively. For protein expression, E. coli Rosetta2 (DE3) cells (Novagen) were transformed with the pET-15b(+)-AmbP1 vector. Cells were grown using auto-induction medium, Fig. S1 . Protein sequence alignment of AmbP1, FidP1 and WelP1.
***********:***.***************************************************:** AmbP1 MNDVNRIRTDIINVAKTFGAEYSEKVLDEVFQVFGEQFADNSFMIRTSNKQPDKLGCYFRYHEEDESQLG 70 FidP1 MNDVNRIRTDIINVAKTFGAEYSEKVLDEVFQVFGEQFADNSFMIRTSNKQPDKLGCYFRYHEEDESQLG 70 WelP1 MNDVNRIRTDIVNVATTFGAEYSEKVLDEVFQVFGEQFADNSFMIRTSNKQPDKLGCYFRYHEEDESHLG 70 *********.*****************:***************************************.** AmbP1 LAWDIARKSGLLSDQGRPVDQLIPEICETFPIMADGVDFDVKHGLAKIWQSIKGVVPVQDAFKLSLPASV 140 FidP1 LAWDIARKSGLLSDQGRPVDQLIPEICETFPIMADGVDFDVKHGLAKIWQSIKGVVPVQDAFKLSLPASV 140 WelP1 LAWDIARKSNLLSDQGRPVDQLIPEICDTFPIMADGVDFDVKHGLAKIWQSIKGVVPVQDAFKLSLPPSV 140 *:*:***************:***************************************:****:***** AmbP1 TTHSDFLKNHHLDALYAFGIDYHHSSVNLYFDTYHPKHHTSEYYKNLLQDLQFQPPSDELLELLTNNGEI 210 FidP1 TTHSDFLKNHHLDALYAFGIDYHHSSVNLYFDTYHPKHHTSEYYKNLLQDLQFQPPSDELLELLTNNGEI 210 WelP1 TAHADFLKNHHLDALYAFGVDYHHSSVNLYFDTYHPKHHTSEYYKNLLQDLQFQPPSDEVLELLANNGEI 210 *******************************.************************************** AmbP1 ALTFNFASPRIERLCFYLPFLNREAVPQNLLNPLLKKYINEAPALVDNPGFILGWSFGPQGGKGTYTKVD 280 FidP1 ALTFNFASPRIERLCFYLPFLNREAVPQNLLNPLLKKYINEAPALVDNPGFILGWSFGPQGGKGTYTKVD 280 WelP1 ALTFNFASPRIERLCFYLPFLNREAVPQNLLTPLLKKYINEAPALVDNPGFILGWSFGPQGGKGTYTKVD 280 ***********:**************** AmbP1 VDYHGRTVPLFMKVHSQPLPKAADFALAQ 309 FidP1 VDYHGRTVPLFMKVHSQPLPKAADFALAQ 309 WelP1 VDYHGRTVPLFIKVHSQPLPKAADFALA-308
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